Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study). J of Skin [Internet]. 2023 Mar. 13 [cited 2025 May 17];7(2):s162. Available from: https://skin.dermsquared.com/skin/article/view/2048